| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |